Nasdaq Soars But Is It Enough? Apple, Celestica, Globus Medical In Focus
Stock Market Today With IBD
00:00
Celestica's Big Rebound and Risk Management
Justin analyzes CLS's 15% pop off the 50-day line and discusses stop placement and position sizing concerns.
Play episode from 19:03
Transcript
